Last 7 days
0.5%
Last 30 days
4.1%
Last 90 days
19.5%
Trailing 12 Months
33.3%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 198.7B | 205.0B | 210.2B | 0 |
2022 | 176.8B | 181.4B | 187.0B | 193.0B |
2021 | 156.6B | 162.5B | 167.4B | 171.3B |
2020 | 153.6B | 152.9B | 154.6B | 156.5B |
2019 | 143.5B | 145.5B | 147.7B | 149.7B |
2018 | 134.4B | 136.8B | 139.4B | 141.9B |
2017 | 128.4B | 130.0B | 130.6B | 132.6B |
2016 | 117.7B | 121.5B | 125.5B | 127.2B |
2015 | 97.9B | 102.5B | 106.5B | 112.4B |
2014 | 93.6B | 91.1B | 90.6B | 93.9B |
2013 | 102.4B | 101.1B | 99.7B | 96.7B |
2012 | 107.6B | 107.6B | 106.6B | 104.8B |
2011 | 100.3B | 102.6B | 105.0B | 106.7B |
2010 | 98.4B | 98.5B | 98.2B | 98.6B |
2009 | 93.8B | 96.0B | 97.3B | 98.1B |
2008 | 0 | 87.4B | 89.6B | 91.7B |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Dec 01, 2023 | weitzman deborah | sold (taxes) | -68,317 | 107 | -638 | ceo, pharmaceutical segment |
Dec 01, 2023 | snow ola m | sold (taxes) | -40,904 | 107 | -382 | chief human resources officer |
Dec 01, 2023 | scherer mary c. | sold (taxes) | -23,236 | 107 | -217 | chief accounting officer |
Nov 27, 2023 | weitzman deborah | acquired | 2,048,360 | 74.103 | 27,642 | ceo, pharmaceutical segment |
Nov 27, 2023 | weitzman deborah | sold | -3,895,410 | 106 | -36,642 | ceo, pharmaceutical segment |
Nov 15, 2023 | hall patricia hemingway | acquired | - | - | 1,965 | - |
Nov 15, 2023 | brennan michelle | acquired | - | - | 1,965 | - |
Nov 15, 2023 | mundkur christine | acquired | - | - | 1,965 | - |
Nov 15, 2023 | mayer jessica l | sold (taxes) | -533,536 | 102 | -5,185 | chief legal/compliance officer |
Nov 15, 2023 | killefer nancy | acquired | - | - | 1,965 | - |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Dec 04, 2023 | TUCKER ASSET MANAGEMENT LLC | added | 53.88 | 164,288 | 562,333 | 0.15% |
Dec 01, 2023 | B. Riley Wealth Advisors, Inc. | reduced | -24.83 | -453,761 | 993,409 | 0.03% |
Nov 28, 2023 | IMA Wealth, Inc. | unchanged | - | -7,332 | 82,132 | 0.02% |
Nov 27, 2023 | USA FINANCIAL FORMULAS | unchanged | - | -171 | 1,910 | -% |
Nov 27, 2023 | TRUST CO OF VERMONT | reduced | -21.93 | -371,725 | 940,434 | 0.06% |
Nov 24, 2023 | EP Wealth Advisors, LLC | new | - | 258,175 | 258,175 | -% |
Nov 24, 2023 | DEUTSCHE BANK AG\ | added | 64.66 | 30,199,200 | 89,222,300 | 0.06% |
Nov 22, 2023 | KBC Group NV | unchanged | - | - | 23,634,000 | 0.10% |
Nov 22, 2023 | Public Sector Pension Investment Board | added | 12.19 | 69,084 | 2,374,700 | 0.02% |
Nov 21, 2023 | TOMPKINS FINANCIAL CORP | unchanged | - | -13,872 | 155,408 | 0.02% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | price t rowe associates inc /md/ | 1.9% | 4,994,087 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 11.95% | 31,320,204 | SC 13G/A | |
Feb 06, 2023 | state street corp | 6.70% | 17,568,683 | SC 13G/A | |
Jan 26, 2023 | blackrock inc. | 11.3% | 29,572,939 | SC 13G/A | |
Jan 20, 2023 | blackrock inc. | 11.3% | 29,572,939 | SC 13G/A | |
Sep 08, 2022 | blackrock inc. | 10.6% | 28,946,151 | SC 13G | |
Feb 14, 2022 | price t rowe associates inc /md/ | 5.3% | 15,028,767 | SC 13G | |
Feb 10, 2022 | state street corp | 7.59% | 21,384,169 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 12.72% | 35,841,618 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 7.8% | 21,999,306 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Dec 05, 2023 | 4 | Insider Trading | |
Dec 05, 2023 | 4 | Insider Trading | |
Dec 05, 2023 | 4 | Insider Trading | |
Dec 04, 2023 | 144 | Notice of Insider Sale Intent | |
Nov 29, 2023 | 4 | Insider Trading | |
Nov 27, 2023 | 144 | Notice of Insider Sale Intent | |
Nov 16, 2023 | 4 | Insider Trading | |
Nov 16, 2023 | 4 | Insider Trading | |
Nov 16, 2023 | 4 | Insider Trading | |
Nov 16, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 182.7B | 40.0B | 10.53% | 1.10% | 35.4 | 4.57 | -11.26% | -34.57% |
BDX | 71.3B | 19.4B | -9.91% | -3.76% | 44.09 | 3.79 | 2.66% | -16.58% |
BAX | 18.2B | 15.0B | 4.18% | -29.75% | 7.01 | 1.21 | 3.01% | 209.09% |
ALGN | 16.6B | 3.8B | 9.66% | 16.57% | 45.78 | 4.36 | -1.48% | -28.97% |
MID-CAP | ||||||||
HSIC | 9.2B | 12.7B | 12.76% | -12.43% | 20.62 | 0.72 | 0.68% | -30.25% |
BIO | 9.0B | 2.7B | 7.54% | -22.26% | -56.74 | 3.32 | -3.01% | 97.36% |
ATR | 8.3B | 3.4B | 0.99% | 18.16% | 29.54 | 2.41 | 3.13% | 18.17% |
XRAY | 6.8B | 3.9B | 12.78% | 6.97% | -31.29 | 1.73 | -2.62% | 73.28% |
AXNX | 2.9B | 342.6M | 7.26% | -12.48% | -242.59 | 8.48 | 42.19% | 84.14% |
PDCO | 2.5B | 6.6B | -13.73% | -8.33% | 12.42 | 0.38 | 2.61% | 0.62% |
SMALL-CAP | ||||||||
AHCO | 1.1B | 3.1B | 0.24% | -60.88% | -2.68 | 0.37 | 7.95% | -550.16% |
ANIK | 321.6M | 163.3M | 3.63% | -28.72% | -13.09 | 1.97 | 7.14% | -56.09% |
ANGO | 272.3M | 335.9M | 0.60% | -44.41% | 42.24 | 0.81 | 4.71% | 116.39% |
APYX | 77.6M | 50.3M | -12.16% | 23.08% | -5.12 | 1.54 | 3.23% | 20.81% |
AEMD | 5.3M | 3.8M | 10.99% | -46.93% | -0.45 | 1.39 | 17.30% | 10.67% |
Income Statement (Quarterly) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | 2.5% | 54,763 | 53,453 | 50,487 | 51,469 | 49,603 | 47,103 | 44,836 | 45,457 | 43,968 | 42,586 | 39,275 | 41,541 | 39,065 | 36,689 | 39,157 | 39,735 | 37,341 | 37,353 | 35,228 | 37,740 | 35,213 |
Gross Profit | -3.2% | 1,768 | 1,827 | 1,785 | 1,663 | 1,614 | 1,605 | 1,682 | 1,616 | 1,642 | 1,475 | 1,812 | 1,776 | 1,715 | 1,590 | 1,885 | 1,714 | 1,679 | 1,674 | 1,764 | 1,730 | 1,667 |
S&GA Expenses | -5.5% | 1,197 | 1,267 | 1,179 | 1,191 | 1,197 | 1,155 | 1,137 | 1,151 | 1,114 | 1,129 | 1,120 | 1,147 | 1,137 | 1,137 | 1,165 | 1,163 | 1,107 | 1,168 | 1,097 | 1,064 | 1,155 |
EBITDA Margin | -100.0% | - | 0.01* | 0.01* | 0.00* | 0.00* | 0.00* | 0.00* | 0.00* | 0.01* | 0.01* | 0.01* | 0.01* | 0.01* | -0.02* | -0.02* | - | - | - | - | - | - |
Interest Expenses | -6.7% | 14.00 | 15.00 | 28.00 | 25.00 | 25.00 | 34.00 | 38.00 | 37.00 | 40.00 | 44.00 | 45.00 | 46.00 | 45.00 | 49.00 | 60.00 | 63.00 | 66.00 | 67.00 | 75.00 | 76.00 | 77.00 |
Income Taxes | -117.1% | -32.00 | 187 | 197 | -7.00 | -1.00 | -165 | 1,253 | -1,022 | 97.00 | 4.00 | 320 | -203 | -410 | 107 | -127 | -59.00 | -423 | 44.00 | 74.00 | 126 | 142 |
Earnings Before Taxes | -121.5% | -26.00 | 121 | 544 | -137 | 110 | -28.00 | -137 | -973 | 369 | 119 | 440 | 427 | -663 | 815 | 478 | 279 | -5,344 | 239 | 370 | 407 | 736 |
EBT Margin | -100.0% | - | 0.00* | 0.00* | 0.00* | -0.01* | 0.00* | 0.00* | 0.00* | 0.01* | 0.00* | 0.01* | 0.01* | 0.01* | -0.02* | -0.03* | - | - | - | - | - | - |
Net Income | 107.8% | 5.00 | -64.00 | 345 | -130 | 110 | 138 | -1,391 | 49.00 | 271 | 116 | 119 | 629 | -253 | 656 | 350 | 220 | -4,922 | 194 | 296 | 280 | 593 |
Net Income Margin | -100.0% | - | 0.00* | 0.00* | -0.01* | -0.01* | -0.01* | -0.01* | 0.00* | 0.01* | 0.00* | 0.01* | 0.01* | 0.01* | -0.02* | -0.03* | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 641 | 1,252 | 512 | -47.00 | 2,828 | -501 | 1,121 | -713 | 539 | 177 | 1,121 | 192 | 104 | 1,586 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | 0.7% | 43,710 | 43,417 | 43,377 | 44,482 | 43,387 | 43,878 | 42,111 | 43,680 | 42,993 | 44,453 | 43,874 | 44,719 | 41,727 | 40,766 | 41,148 | 41,042 | 39,179 | 40,963 | 40,809 | 40,462 | 40,011 |
Current Assets | 2.5% | 34,688 | 33,833 | 33,497 | 34,596 | 32,696 | 32,935 | 30,884 | 31,847 | 29,731 | 31,048 | 30,362 | 30,113 | 27,030 | 25,940 | 25,848 | 25,736 | 23,715 | 25,747 | 25,582 | 25,091 | 24,445 |
Cash Equivalents | -4.7% | 3,854 | 4,043 | 3,990 | 3,654 | 3,492 | 4,717 | 2,356 | 3,161 | 2,463 | 3,407 | 3,499 | 3,737 | 2,746 | 2,771 | 2,329 | 1,659 | 1,212 | 2,531 | 3,438 | 2,182 | 2,045 |
Inventory | 6.6% | 16,987 | 15,940 | 16,620 | 17,263 | 15,891 | 15,636 | 15,493 | 14,941 | 14,720 | 14,594 | 14,329 | 14,443 | 13,439 | 13,198 | 12,808 | 13,799 | 12,458 | 12,822 | 12,622 | 13,037 | 12,481 |
Net PPE | -0.9% | 2,441 | 2,462 | 2,362 | 2,341 | 2,339 | 2,361 | 2,298 | 2,321 | 2,336 | 2,360 | 2,315 | 2,386 | 2,369 | 2,366 | 2,299 | 2,301 | 2,324 | 2,356 | 2,322 | 2,376 | 2,436 |
Current Liabilities | 4.0% | 35,065 | 33,706 | 32,503 | 33,212 | 31,559 | 30,550 | 28,715 | 27,729 | 26,499 | 27,624 | 25,323 | 25,750 | 24,016 | 23,615 | 24,671 | 24,890 | 22,549 | 24,109 | 23,919 | 23,824 | 23,057 |
Long Term Debt | -0.5% | 3,890 | 3,909 | 4,708 | 4,685 | 4,689 | 4,735 | 4,751 | 5,342 | 5,353 | 5,365 | 6,715 | 6,720 | 6,728 | 6,765 | 6,754 | 6,742 | 7,360 | 7,579 | 7,629 | 7,599 | 7,999 |
Shareholder's Equity | -22.4% | -3,490 | -2,851 | - | - | -1,780 | -706 | - | 1,002 | 1,396 | 1,794 | 1,794 | 1,975 | 1,425 | 1,792 | 1,206 | 1,002 | 903 | 6,330 | 6,232 | 6,043 | 5,913 |
Retained Earnings | -22.5% | -654 | -534 | -342 | -560 | -301 | -280 | -281 | 1,245 | 1,335 | 1,205 | 1,233 | 1,255 | 771 | 1,170 | 656 | 449 | 371 | 5,434 | 5,386 | 5,233 | 5,097 |
Shares Outstanding | - | - | - | 256 | 261 | 271 | - | 275 | 279 | 287 | - | 292 | 294 | 293 | - | 292 | 292 | 296 | - | 298 | 299 | 305 |
Minority Interest | 0% | 1.00 | 1.00 | 2.00 | 1.00 | 1.00 | 3.00 | 4.00 | 4.00 | 3.00 | 3.00 | 4.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | - | - |
Cashflow (Quarterly) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | -36.5% | 545 | 858 | 1,361 | 597 | 23.00 | 2,992 | -419 | 1,195 | -646 | 665 | 277 | 1,217 | 270 | 240 | 1,676 | 697 | -653 | 506 | 1,480 | 371 | 365 |
Share Based Compensation | 7.4% | 29.00 | 27.00 | 21.00 | 25.00 | 23.00 | 16.00 | 23.00 | 18.00 | 24.00 | 5.00 | 33.00 | 23.00 | 28.00 | 22.00 | 27.00 | 21.00 | 20.00 | 18.00 | 23.00 | 22.00 | 19.00 |
Cashflow From Investing | 69.4% | -63.00 | -206 | -91.00 | -87.00 | -70.00 | -204 | -44.00 | -47.00 | 862 | -88.00 | -99.00 | -97.00 | -94.00 | 742 | -98.00 | -78.00 | -73.00 | -173 | -84.00 | -84.00 | 679 |
Cashflow From Financing | -12.5% | -666 | -592 | -934 | -362 | -1,163 | -415 | -340 | -444 | -1,264 | -649 | -324 | -146 | -198 | -528 | -912 | -175 | -585 | -1,243 | -142 | -144 | -764 |
Dividend Payments | 4.0% | 131 | 126 | 128 | 129 | 142 | 134 | 136 | 140 | 149 | 141 | 143 | 143 | 146 | 141 | 141 | 141 | 146 | 142 | 142 | 143 | 150 |
Buy Backs | 0% | 500 | 500 | 250 | 250 | 1,000 | - | 200 | 300 | 500 | - | 200 | - | - | - | - | - | 350 | - | - | - | 600 |
Condensed Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | |
Income Statement [Abstract] | ||
Revenue | $ 54,763 | $ 49,603 |
Cost of Goods and Services Sold | 52,995 | 47,989 |
Gross margin | 1,768 | 1,614 |
Operating expenses: | ||
Distribution, selling, general and administrative expenses | 1,197 | 1,197 |
Restructuring and employee severance | 25 | 29 |
Amortization and other acquisition-related costs | 64 | 71 |
Impairments and (gain)/loss on disposal of assets, net | 537 | 153 |
Litigation (recoveries)/charges, net | (41) | 27 |
Operating earnings/(loss) | (14) | 137 |
Other (income)/expense, net | (2) | 2 |
Interest expense, net | 14 | 25 |
Earnings/(loss) before income taxes | (26) | 110 |
Benefit from income taxes | (32) | (1) |
Net earnings | 6 | 111 |
Less: Net earnings attributable to noncontrolling interests | (1) | (1) |
Net earnings attributable to Cardinal Health, Inc. | $ 5 | $ 110 |
Earnings per common share attributable to Cardinal Health, Inc.: | ||
Basic (in shares) | $ 0.02 | $ 0.41 |
Diluted (in shares) | $ 0.02 | $ 0.40 |
Weighted-average number of common shares outstanding: | ||
Basic (in shares) | 249 | 271 |
Diluted (in shares) | 250 | 273 |
Cash dividends declared per common share | $ 0.5006 | $ 0.4957 |
Condensed Consolidated Balance Sheets - USD ($) shares in Thousands, $ in Millions | Sep. 30, 2023 | Jun. 30, 2023 |
---|---|---|
Current assets: | ||
Cash and equivalents | $ 3,854 | $ 4,043 |
Trade receivables, net | 11,265 | 11,344 |
Inventories, net | 16,987 | 15,940 |
Prepaid expenses and other | 2,582 | 2,362 |
Assets held for sale | 0 | 144 |
Total current assets | 34,688 | 33,833 |
Property and equipment, net | 2,441 | 2,462 |
Goodwill and other intangibles, net | 5,432 | 6,081 |
Other Assets | 1,149 | 1,041 |
Total assets | 43,710 | 43,417 |
Current liabilities: | ||
Accounts Payable, Current | 31,540 | 29,813 |
Current portion of long-term obligations and other short-term borrowings | 788 | 792 |
Other accrued liabilities | 2,737 | 3,059 |
Liabilities related to assets held for sale | 0 | 42 |
Total current liabilities | 35,065 | 33,706 |
Long-term obligations, less current portion | 3,890 | 3,909 |
Deferred income taxes and other liabilities | $ 8,245 | $ 8,653 |
Preferred shares, without par value: | ||
Preferred Stock, Shares Authorized | 500 | 500 |
Preferred Stock, Shares Issued | 0 | 0 |
Preferred Stock, Value, Issued | $ 0 | $ 0 |
Common shares, without par value: | ||
Common Stock, Shares Authorized | 755,000 | 755,000 |
Common Stock, Shares, Issued | 327,000 | 327,000 |
Common Stock, Value, Issued | $ 2,728 | $ 2,747 |
Accumulated deficit | (654) | (534) |
Treasury Stock, Value | $ (5,400) | $ (4,914) |
Treasury Stock, Shares | 80,000 | 76,000 |
Accumulated other comprehensive loss | $ (165) | $ (151) |
Total Cardinal Health, Inc. shareholders' deficit | (3,491) | (2,852) |
Noncontrolling interests | 1 | 1 |
Total shareholders' equity | (3,490) | (2,851) |
Total liabilities and shareholders’ deficit | $ 43,710 | $ 43,417 |
 CEO | Mr. Jason M. Hollar |
---|---|
 WEBSITE | www.cardinalhealth.com |
 EMPLOYEES | 47040 |